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Abstract Lipopolysaccharide (LPS)-induced differentiation of
the murine pre-B cell line 70Z/3 is a model for pre-B to B cell
differentiation and has been used to show that the transcription
factor NF-UB is essential to induce the expression of the IgU
gene. We have investigated the mechanism involved in late stages
of the process when all cells have reached a more mature B
phenotype, i.e. beyond 48 up to 96 h of LPS treatment. NF-UB
binding activity was induced at early times by LPS treatment,
but its DNA binding activity disappeared after 84 h of LPS
treatment. Accumulation of IUBK protein in the nucleus
correlated with the disappearance of NF-UB activity at 72, 84
and 96 h, and treatment of nuclear extracts of 72^96 h LPS-
treated cells with Na-deoxycholate restored NF-UB binding
activity. The data indicate that NF-UB, while important to
initiate the process of IgU gene transcription in 70Z/3 pre-B cells,
is no longer required for its maintenance in differentiated 70Z/3
cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The pre-B 70Z/3 cell line represents a useful system for
studying certain events of early B cell di¡erentiation [1,2].
70Z/3 cells contain a functionally rearranged but transcrip-
tionally inactive IgU locus. The activation of immunoglobulin
transcription that occur in B cells is mediated by multiple cell-
type-speci¢c promoters and enhancers. Immunoglobulins pro-
moters (W, U, V) contain a highly conserved octanucleotide
element essential for the expression of transfected immunoglo-
bulin gene constructs in B cells [3,4]. The intronic U enhancer
also contains binding sites for the transcription factor NF-UB
[5] required for B cell-speci¢c demethylation and transcrip-
tional activation of the locus [6,7]. NF-UB belongs to a family
of transcription factors composed of ¢ve members (NFKB1,
NFKB2, RelA, c-Rel and RelB), which share a 300 amino
acid Rel homology domain and forming hetero- and homo-
dimers [8]. NF-UB activity is regulated by speci¢c inhibitors
(IUB) that maintain the factor in a cytoplasmic, inactive form
[9]. Several inducers cause dissociation and degradation of
IUBs, and promote activation of NF-UB with a rapid trans-
location into the nucleus, where it directly regulates gene ex-
pression. While NF-UB factors are widely expressed in almost
all cell types analysed so far, NF-UB has been reported to be
constitutively activated only in mature B and T cells and in
regions of the mouse brain [10^13]. The composition of NF-
UB dimers is thought to change during the transition from
pre-B to B cells [10,14,15]. On the other hand, resting fresh
mouse spleen B cells do not contain NF-UB in the nucleus
[16]. Others have reported that these cells contain NF-UB
both in the nucleus and in the cytoplasm, with the cytoplasmic
fraction being inducible by lipopolysaccharide (LPS) treat-
ment [17]. Here we show that upon LPS treatment, 70Z/3 cells
are induced to di¡erentiate; a biphasic induction of IgU and
IUBK mRNA was observed, the initial phase correlated with
nuclear translocation of NF-UB, while the second phase did
not. At late time points of LPS treatment, NF-UB nuclear
activity disappeared. Nuclear accumulation of IUBK corre-
lated with down-regulation of NF-UB DNA binding activity.
Nuclear extracts at this stage contained NF-UB binding activ-
ity which could be revealed only upon dissociation of NF-UB/
IUB complexes. Thus, nuclear IUBK is likely the cause of NF-
UB down-regulation. These data show that activation of NF-
UB is required for the initiation of transcription of the IgU
gene in 70Z/3 pre-B cells, but not for its maintenance in di¡er-
entiated 70Z/3 cells.
2. Materials and methods
2.1. Cell culture
HeLa and A549 cells were grown in DMEM medium supplemented
with 10% calf serum, 0.01% penicillin-streptomycin and 2 mM L-glu-
tamine. Murine pre-B cells 70Z/3 were grown in RPMI 1640 medium
supplemented with 10% foetal calf serum, 0.01% penicillin-streptomy-
cin, 2 mM L-glutamine with the addition of 50 WM 2-mercaptoetha-
nol. 70Z/3 were stimulated with LPS (Escherichia coli) at a ¢nal con-
centration of 10 Wg/ml [1].
2.2. Cytoplasmic and nuclear extracts and electrophoretic mobility shift
assay (EMSA)
Nuclear and cytoplasmic extracts from cultured cells were prepared
by standard procedures according to published methods [18]. The
oligonucleotides used for EMSA were 5P-labelled with [Q-32P]ATP,
T4 polynucleotide kinase and were as follows:
UB: 5P-GCTGCCTGCTGGGGAAAGTAC-3P [19];
Oct: 5P-CATGAATATGCAAATCAGGTGAGTCTAT-3P [20].
Cytosolic extracts were treated with sodium desoxycholate for 10 min
on ice to release NF-UB from IUB prior to the addition of the poly
[d(I-C)], as previously described [21].
2.3. Western immunoblot analysis
10 Wg of cytoplasmic and 5 Wg of nuclear extracts were separated on
a 10% SDS-polyacrylamide gel and transferred to a nitrocellulose
membrane (Bio-Rad). The blot was incubated with a 1:2000 dilution
of the di¡erent antibodies (Santa Cruz Biotechnology, USA). The blot
was developed according to the manufacturer’s instructions (ECL,
Amersham, UK).
2.4. Northern analysis
Total RNA was extracted from cells by the guanidinium isothio-
cyanate method [22]. 5 Wg of total RNAs was loaded on a 1% agarose-
formaldehyde gel and transferred to a nitrocellulose membrane (Bio-
Rad). The following fragments were used as probes: a 0.317 kb frag-
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ment from the human IgU constant coding region was ampli¢ed by
PCR from the plasmid p160 Mk6, with the following primers:
5P-CATTCCTGTTGAAGC-3P ;
5P-GCTGATGCTGCACCA-3P.
The 1 kb IUBK cDNA was extracted from the RcCMV/
MAD3 plasmid [21]. The rat GAPDH fragment [23] was
used for normalisation of RNA loading. Fragments were la-
belled with [K-P32]dCTP by the Random Primed DNA label-
ling kit (Boehringer). The intensity of RNA bands in the auto-
radiographs were quantitated by a video densitometer (Umax,
Vista Speed).
3. Results
3.1. Pre-B 70Z/3 cells di¡erentiate under prolonged
LPS treatment
Previous studies with LPS-treated 70Z/3 cells were followed
for no longer than 24/72 h [10,14]. In order to examine the
maintenance of the di¡erentiated state, we initially determined
the optimal starting cell density that would allow at least
4 days (96 h) of LPS treatment with still vital and healthy
cells. As shown in Fig. 1A, with a starting cell density of
2U104 cells/ml, the growth curves of untreated and LPS-
treated 70Z/3 were essentially the same up to 72 h. The num-
ber of LPS-treated cells did not decrease up to 96 h, suggest-
ing that no cell death was occurring under this culture con-
ditions. Dilution of the cells in fresh medium after 72 h of
LPS treatment did not stimulate further cell division, an in-
dication of pre-B to B cell transition (Fig. 1B).
To verify the LPS-induced di¡erentiation of 70Z/3 cells, we
measured the expression of the IgU mRNA and protein. IgU
mRNA (Fig. 2A) was induced after 24 h of LPS treatment
(lane 4), remaining constant at 48 and 72 h (lanes 5 and 6). A
further increase was observed at 84 and 96 h (lanes 7 and 8).
The IgU protein became detectable in the cytoplasmic extracts
after 24 h of LPS (Fig. 2B, lane 5). These data indicate that
pre-B 70Z/3 cells di¡erentiate to mature IgM-secreting B cells
under our culture conditions. We then used these cultures
conditions for the subsequent experiments.
3.2. NF-UB is down-regulated at late time points of
LPS treatment
In order to investigate the activation state of NF-UB and
Oct-2 transcription factors in 70Z/3 cells upon LPS treatment,
we prepared nuclear extracts from untreated and LPS-treated
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Fig. 1. Pre-B 70Z/3 cells di¡erentiate upon LPS treatment. A: 70Z/3 cells were seeded at a starting cell density of 2U104 cells/ml. LPS was
added 2 h after seeding. Vital counts of LPS-treated and untreated cells were taken every 24 h. a, untreated cells ; b, LPS-treated cells. B:
After 72 h of LPS treatment cells were diluted 1:3 in fresh medium containing no serum (¢nal serum concentration 3.3%) and the growth rate
of these cells was compared to untreated 70Z/3 cells grown in 3.3% serum. 7, LPS-treated cells ; F, untreated cells.
Fig. 2. Induction of IgU mRNA and protein upon LPS-induced dif-
ferentiation. A: Northern analysis of total mRNA extracted from
70Z/3 cells. IgU mRNA was not detected in untreated cells (lane 1)
or in cells treated for 0.5 and 2 h with LPS (lanes 2 and 3). After
24 h IgU mRNA was detected (lane 4), it remained constant at 48
and 72 h (lanes 5 and 6) and increased at 84 and 96 h (lanes 7 and
8). IUBK mRNA expression was induced upon LPS treatment after
2 h (lane 3). At 84 h (lane 8) increased again. As control for RNA
loading the ¢lter was hybridised with a GAPDH probe. B: Immu-
noblot analysis of 70Z/3 cytoplasmic extracts. IgU protein was not
detected in untreated cells (lane 2) and in cells treated for 0.5 and 2
h with LPS (lanes 3 and 4). After 24 h IgU protein was detected
(lane 5) increasing at 48 and 72 h (lanes 6 and 7). Further increase
was observed at 96 h (lane 9). Lane 1: HeLa cytoplasmic extracts
were used as negative control.
L. Guerrini et al./FEBS Letters 434 (1998) 140^144 141
cells, and performed electrophoretic mobility shift assay
(EMSA). As shown in Fig. 3, NF-UB binding activity was
absent in untreated cells (lane 2), but was induced after 0.5 h
of LPS treatment (lane 3) and remained activated up to 72 h
(lanes 4^8), then steadily declined afterwards and was essen-
tially absent at 96 h of treatment (lane 10). Oct-1 binding
activity was not a¡ected by the LPS treatment (lanes 2^10)
while Oct-2, not present in untreated cells (lane 2), was in-
duced early in the process and remained high throughout the
96 h of the experiment (lanes 3^10).
These data indicate a temporal discrepancy between IgU
expression and NF-UB activation at late stages of LPS treat-
ment.
3.3. NF-UB down-regulation at late time points of LPS
treatments is not due to NF-UB subunit degradation
To verify if NF-UB down-regulation at late time points of
LPS treatments could be due to NF-UB subunit degradation,
we used cytoplasmic and nuclear extracts from LPS-treated
cells in immunoblot experiments. The RelA subunit remained
constant in both the cytoplasm and nuclei for the 96 h of the
experiment (Fig. 4). c-Rel, NFKB1 and NFKB2 were induced
in both the cytoplasm and nuclei shortly after LPS addition.
RelB was induced last, after 24 h of LPS treatment.
The IUBL protein decreased in the cytoplasm after 0.5 h of
LPS treatment (Fig. 4, lane 2), being completely absent after
2 h (lane 3). After 24 h de novo synthesised IUBL protein
became visible and remained constant thereafter (lanes 4^8).
In the nuclear extracts we could not detect the IUBL protein.
On the other hand, LPS treatment of 70Z/3 cells did not result
in IUBK protein degradation in either cytoplasm or nuclei. An
accumulation of IUBK is visible in the nuclear extracts at 72,
84 and 96 h (lanes 14, 15 and 16). Northern analysis of RNA
extracted from 70Z/3 cells revealed an initial increase of IUBK
mRNA after 2 h of LPS, but after 72 h of LPS treatment,
IUBK mRNA levels increased again (Fig. 2A).
The presence of all NF-UB subunits and inhibitors both in
cytoplasmic and nuclear extracts at late LPS time points dem-
onstrate that mechanisms other than NF-UB subunits degra-
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Fig. 4. Down-regulation of NF-UB DNA binding activity is not due to NF-UB subunit degradation. Immunoblot analysis of NF-UB subunits
of 70Z/3 cells cytoplasmic and nuclear extracts. All subunits were present in both the cytoplasm and nuclear extracts of untreated cells (lanes 1
and 9, respectively). RelA expression was not induced by LPS, while c-Rel, NFKB1, NFKB2 and RelB were induced with di¡erent kinetics.
IUBL decreased after 0.5 h of LPS (lane 2) and after 2 h it was completely degraded (lane 3). After 24 h, IUBL was visible again and remained
constant thereafter (lanes 4^8). IUBK was not degraded in the cytoplasm upon LPS treatment (lanes 1^8); in the nuclear extracts an increase of
the IUBK protein was detected after 72, 84 and 96 h of LPS (lanes 14, 15 and 16).
Fig. 3. NF-UB is down-regulated at late time points of LPS treat-
ment. A: Nuclear extracts of 70Z/3 cells were analysed for NF-UB
binding activity to an oligonucleotide reproducing the double HIV
NF-UB site and to an oligonucleotide reproducing the Oct site from
the VH promoter region. Untreated cells had no NF-UB binding ac-
tivity (lane 2), but after 0.5 h of LPS NF-UB activity was induced
(lane 3), and it remained constant up to 48 h (lanes 4^7). After 84 h
NF-UB binding activity started to decline (lane 9), and at 96 h was
absent as in untreated cells (lane 10). Oct-1 binding activity was not
in£uenced by LPS treatment (lanes 2^10). Oct-2 was sligthly detect-
able in untreated cells (lane 2) but was rapidly induced by LPS
(lanes 3^10). Lane 1: nuclear extracts from HeLa cells were used as
control.
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dation, must be involved in down-regulation of NF-UB DNA
binding activity.
3.4. Nuclear accumulation of IUBK could account for
down-regulation of NF-UB DNA binding activity
The timing of IUBK protein accumulation in the nuclear
extracts at 72^96 h correlates with down regulation of NF-
UB DNA binding activity. In order to verify if nuclear accu-
mulation of IUBK after 72 h of LPS treatment was involved in
the decrease of NF-UB binding activity, nuclear extracts of
untreated and LPS-treated cells for 72, 84 and 96 h were
activated with the detergent deoxycholate in order to release
the IUB-bound NF-UB and used in EMSA. An increase in
detergent-activated NF-UB binding activity was observed
(Fig. 5, lanes 2, 3 and 4).
These data suggest that de novo synthesised nuclear IUBK
could be responsible for decreased NF-UB binding activity at
late time points of LPS treatment.
4. Discussion
Previous studies have shown that NF-UB complexes are
retained in the cytoplasm of pre-B cell lines, while in B cell
lines NF-UB complexes are constitutively nuclear with devel-
opmental stage-speci¢c changes in subunits composition
[10,14]. 70Z/3 cells have been widely used as model of B cell
di¡erentiation, since treatment with LPS leads to di¡erentia-
tion towards a more mature B cell phenotype. This process
has been thoroughly studied, but in all cases the time of in-
duction has been limited to the ¢rst 72 h. We have determined
conditions to extend these studies beyond this time (Fig. 1),
and have therefore analysed this process up to 96 h, a time in
which cells may have gone beyond the pre-B cell stage, since
they do produce IgU (Fig. 2) and have lost the ability to
reproduce (Fig. 1B). Under these conditions, we found that
no active NF-UB was present in nuclei at late time points of
LPS treatment (Fig. 3), which implies that this factor is not
required for the maintenance of this phenotype. On the other
hand, the ubiquitous Oct-1 factor is not a¡ected by the LPS
treatment, while the B cell-speci¢c factor Oct-2 is induced at
early times by LPS and remains high through the 96 h (Fig.
3). Thus this factor may be involved in U gene expression.
This would be in agreement with previous studies with 70Z/
3 cells, where TGF-L treatment of LPS-stimulated cells
blocked both U gene and Oct-2 expression but not NF-UB
activation, demonstrating that NF-UB by itself is necessary
but not su⁄cient to induce U gene expression [24]. Our failure
to detect NF-UB in mature 70Z/3 cells is consistent with the
¢nding that primary splenic mouse B cells lack constitutive
NF-UB binding activity [25], suggesting that the role of NF-
UB in B cells could be important for developmental cellular
processes but not for the maintenance of the di¡erentiated
phenotype.
The presence of all NF-UB subunits at late LPS time points
demonstrates that mechanisms other than NF-UB subunits
degradation must be involved in down-regulation of NF-UB
DNA binding activity (Fig. 4). The absence of nuclear NF-UB
DNA binding activity at late LPS time points appears to be
due to an intranuclear inhibition, since treatment of nuclear
extracts with sodium deoxycholate restores the DNA binding
activity (Fig. 5). While we cannot exclude that other inhibitors
are involved in this process, our data suggest that nuclear
IUBK is responsible for inhibition of NF-UB DNA binding
activity. Moreover, we could not ¢nd evidence of the presence
of IUBL in the nucleus, while we could easily detect it in the
cytoplasm. Indeed, we found an increase of IUBK protein (Fig.
4) in the nucleus. Evidence for a role of the nuclear export
sequences present in the C-terminal domain of IUBK in the
export of NF-UB from the nucleus has also been recently
provided [26,27]. Together these data converge to indicate
that following its nuclear translocation, IUBK releases NF-
UB from its target sites and consequently down-regulates
NF-UB-dependent transcription.
The B cell-speci¢c transcription factor Oct-2, almost absent
in unstimulated 70Z/3 cells, rapidly increased upon LPS treat-
ment and remained high for the whole 96 h of the experiment.
Oct-2, rather than NF-UB, seems to be crucial for B cell ter-
minal di¡erentiation. NFKB1, c-Rel and RelB knock-out
mice do not display a defect in B lymphocyte di¡erentiation
[28^30], although in the various knock-out animals other
members of the NF-UB/Rel family might substitute for one
another producing no major phenotypic alteration. In fact,
NF-UB appears to be essential in B cell maturation, as double
recombinant mice lacking both NFKB1 and NFKB2 genes
did not produce mature B cells [31]. On the other hand,
Oct-2 knock-out mice contain normal numbers of B cell pre-
cursors but are somehow de¢cient in IgM B cells [32]. Oct-2
is not required for the generation of immunoglobulin-bearing
B cells but is crucial for their maturation to immunoglobulin
secreting cells. Thus Oct-2 induction may be essential to es-
tablish and maintain U gene transcription in mature B cells.
NF-UB and Oct-2 may act in a combinatorial manner to
initiate the stage-speci¢c expression of the U locus. According
to this model, in the pre-B cell, NF-UB is cytoplasmically
localised in an inactive complex with the inhibitors IUBK
and IUBL. The Oct-2 protein is present at low levels and un-
able to stimulate U gene transcription in the absence of NF-
UB. A di¡erentiation signal like LPS results in rapid dissoci-
ation of NF-UB from IUBL and translocation of the former to
the nucleus. Upon binding, the UB motif in the U gene intron
enhancer, NF-UB, in concert with the pre-existing Oct-2 pro-
tein, may stimulate low-level U gene transcription.
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Fig. 5. NF-UB DNA binding activity is restored by deoxycholate
treatment. Nuclear extracts of untreated cells (lane 1) and cells
treated for 72, 84 and 96 h with LPS (lanes 2, 3 and 4) were treated
with detergents in order to release the IUB-bound NF-UB and ana-
lysed for NF-UB binding activity to an oligonucleotide reproducing
the double HIV NF-UB site.
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